Summit Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 05/15/2026 | 36.39 M | $689.97 M | 0.00% | 4.87% |
| FMR LLC | 05/15/2026 | 10.85 M | $205.78 M | -18.77% | 1.45% |
| BLACKROCK, INC. | 05/13/2026 | 9.65 M | $183.04 M | 3.12% | 1.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 8.28 M | $156.95 M | -11.67% | 1.11% |
| STATE STREET CORP | 05/15/2026 | 7.03 M | $133.25 M | 5.90% | 0.94% |
| 05/15/2026 | 5.71 M | $108.30 M | 100.00% | 0.76% | |
| 05/08/2026 | 5.23 M | $99.22 M | 100.00% | 0.70% | |
| UBS GROUP AG | 05/05/2026 | 3.68 M | $69.78 M | 322.68% | 0.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.32 M | $62.89 M | 5.35% | 0.44% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 2.24 M | $42.51 M | 439.93% | 0.30% |
| MORGAN STANLEY | 05/15/2026 | 1.65 M | $31.30 M | 78.14% | 0.22% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 1.32 M | $23.96 M | -4.38% | 0.18% |
| APEIRON CAPITAL LTD | 04/22/2026 | 1.31 M | $24.82 M | -0.01% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.24 M | $23.50 M | -31.25% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 981.19 K | $18.60 M | 69.68% | 0.13% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 960.87 K | $18.22 M | 7.64% | 0.13% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 956.89 K | $18.14 M | -20.61% | 0.13% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 934.39 K | $17.72 M | 100.00% | 0.13% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/14/2026 | 892.87 K | $16.93 M | 100.00% | 0.12% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 784.19 K | $14.87 M | 100.00% | 0.10% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 710.00 K | $13.46 M | 0.00% | 0.10% |
| ABRDN PLC | 04/29/2026 | 665.36 K | $12.62 M | -28.24% | 0.09% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 613.88 K | $11.64 M | -14.19% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 603.93 K | $11.45 M | 100.00% | 0.08% |
| LMR PARTNERS LLP | 05/15/2026 | 600.40 K | $11.38 M | 41.47% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 598.69 K | $11.35 M | 25.41% | 0.08% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 592.81 K | $11.24 M | 34.44% | 0.08% |
| NORTHERN TRUST CORP | 05/14/2026 | 581.60 K | $11.03 M | 10.05% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 567.50 K | $10.76 M | -61.22% | 0.08% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 548.34 K | $10.40 M | 990.17% | 0.07% |
| CANDRIAM S.C.A. | 04/30/2026 | 540.66 K | $10.25 M | 0.00% | 0.07% |
| INVESCO LTD. | 05/12/2026 | 526.10 K | $9.97 M | 14.05% | 0.07% |
| CITADEL ADVISORS LLC | 05/15/2026 | 505.60 K | $9.59 M | 58.59% | 0.07% |
| MARSHALL WACE, LLP | 05/15/2026 | 475.24 K | $9.01 M | 100.00% | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 443.76 K | $8.11 M | 24.00% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2026 | 441.74 K | $8.38 M | -82.16% | 0.06% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 404.68 K | $7.67 M | 14.40% | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2026 | 384.99 K | $7.30 M | -9.00% | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 362.86 K | $6.88 M | 100.00% | 0.05% |
| QVT FINANCIAL LP | 05/15/2026 | 360.52 K | $6.84 M | 0.00% | 0.05% |
| NOMURA HOLDINGS INC | 05/15/2026 | 313.98 K | $5.95 M | -42.09% | 0.04% |
| E FUND MANAGEMENT CO., LTD. | 04/13/2026 | 311.83 K | $5.91 M | 100.00% | 0.04% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 310.73 K | $5.89 M | -36.01% | 0.04% |
| RAFFERTY ASSET MANAGEMENT, LLC | 05/15/2026 | 259.07 K | $4.91 M | -9.98% | 0.03% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 256.26 K | $4.86 M | 100.00% | 0.03% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/14/2026 | 251.39 K | $4.27 M | 0.00% | 0.03% |
| NUVEEN, LLC | 04/30/2026 | 243.99 K | $4.63 M | 4.88% | 0.03% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 237.79 K | $4.51 M | 0.00% | 0.03% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 230.00 K | $4.36 M | -4.17% | 0.03% |
| WOODLINE PARTNERS LP | 05/15/2026 | 214.51 K | $4.07 M | 0.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 272 institutional investors and hedge funds held shares of Summit Therapeutics Inc. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 36.39 M
FMR LLC: 10.85 M
BlackRock, Inc.: 9.65 M
PRICE T ROWE ASSOCIATES INC /MD/: 8.28 M
STATE STREET CORP: 7.03 M
UBS Group AG: 3.68 M
15.90% of Summit Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 134.64 M shares in the last 24 months. This purchase volume represents approximately $2.12 B in transactions.